Clinical Trials Browser

Not yet recruiting × HER2-positive Breast Cancer × Docetaxel × Clear all

NCT07116824 2025-08-12

HB1801 Combined Treatment of HER2-positive Breast Cancer

Phase 2 Not yet recruiting

HER2-positive Breast Cancer